Zobrazeno 1 - 10
of 253
pro vyhledávání: '"Gelmon, Karen"'
Autor:
Chapman JW; Canadian Cancer Trials Group Queen's University, Kitchener, Canada., Bayani J; Ontario Institute for Cancer Research, Toronto, Canada.; University of Toronto, Toronto, Canada., SenGupta S; Queen's University, Kingston, Canada., Bartlett JMS; University of Edinburgh, Edinburgh, United Kingdom., Piper T; University of Edinburgh, Edinburgh, United Kingdom., Quintayo MA; Ontario Institute for Cancer Research, Toronto, Canada., Virk S; Canadian Cancer Trials Group Queen's University, Kingston, Canada., Goss PE; Harvard University, Boston, MA., Ingle JN; Harvard University, Boston, MA., Ellis MJ; Progendis, Gaithersburg, MD., Sledge GW; Caris Life Sciences, Irving, TX., Budd GT; Cleveland Clinic, Cleveland, OH., Rabaglio M; Inselspital Bern, Bern, Switzerland., Ansari RH; Indiana School of Medicine, South Bend, IN., Tozer R; McMaster University, Hamilton, Canada., D'Souza DP; London Regional Health Science Centre, London, Canada., Chalchal H; Alan Blair Cancer Center, Regina, Canada., Spadafora S; Algoma Regional Cancer Centre, Sault Ste Marie, Canada., Stearns V; Weill Cornell Medicine, New York, NY., Perez EA; Harvard University, Boston, MA.; Mayo Clinic, Redwood City, CA., Gelmon KA; University of British Columbia, Vancouver, Canada., Whelan TJ; McMaster University, Hamilton, Canada., Elliott C; Canadian Cancer Trials Group Queen's University, Kingston, Canada., Shepherd LE; Canadian Cancer Trials Group Queen's University, Kingston, Canada., Chen BE; Canadian Cancer Trials Group Queen's University, Kingston, Canada., Taylor KJ; University of Edinburgh, Edinburgh, United Kingdom.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Aug 20; Vol. 42 (24), pp. 2887-2898. Date of Electronic Publication: 2024 Jun 02.
Autor:
Cardoso F; Breast Unit, Champalimaud Clinical Centre/Champalimaud Foundation, and ABC Global Alliance, Lisbon, Portugal. Electronic address: fatimacardoso@fundacaochampalimaud.pt., Paluch-Shimon S; Hadassah University Hospital - Sharett Institute of Oncology, Jerusalem, Israel., Schumacher-Wulf E; Mamma Mia, Kronberg, Germany., Matos L; Breast Unit, Champalimaud Clinical Centre/Champalimaud Foundation, Lisbon, Portugal., Gelmon K; BC Cancer Agency, Department of Medical Oncology, Vancouver, Canada., Aapro MS; Cancer Center, Clinique de Genolier, Genolier, Switzerland., Bajpai J; Tata Memorial Centre, HBNI, Mumbai, India., Barrios CH; Latin American Cooperative Oncology Group (LACOG), Grupo Oncoclínicas, Porto Alegre, Brazil., Bergh J; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden., Bergsten-Nordström E; Europa Donna - the European Breast Cancer Coalition, Norrkoping, Sweden., Biganzoli L; Department of Oncology, Hospital of Prato - Azienda USL Toscana Centro Prato, Italy and European Society of Breast Cancer Specialists (EUSOMA), Italy., Cardoso MJ; Breast Unit, Champalimaud Clinical Centre/Champalimaud Foundation and Lisbon University, Faculty of Medicine, Lisbon, Portugal., Carey LA; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, USA., Chavez-MacGregor M; Health Services Research, Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, USA and American Society of Clinical Oncology (ASCO), Houston, USA., Chidebe R; Project PINKBLUE, Abuja, Nigeria., Cortés J; International Breast Cancer Center (IBCC), Madrid and Barcelona, Spain., Curigliano G; European Institute of Oncology, IRCCS, Milano, Italy; Department of Oncology and Hemato-Oncology, University of Milano, Milano, Italy., Dent RA; National Cancer Center Singapore, Singapore, Singapore., El Saghir NS; NK Basile Cancer Institute, American University of Beirut Medical Center, Beirut, Lebanon., Eniu A; Hôpital Riviera-Chablais, Vaud-Valais Rennaz, Switzerland and European School of Oncology (ESO), United Kingdom., Fallowfield L; Brighton & Sussex Medical School, University of Sussex, Brighton, United Kingdom., Francis PA; Department of Medical Oncology, Peter MacCallum Cancer Centre, Sir Peter MacCallum Department of Oncology, University of Melbourne, Australia., Franco Millan SX; CTIC, Cancer Treatment and Research Center, Bogotá, Colombia., Gilchrist J; Macquarie University, Sydney, Australia., Gligorov J; Department of Medical Oncology, Cancer Est APHP Tenon, University Paris VI, Nice/St Paul Guidelines, Paris, France., Gradishar WJ; Northwestern Medicine, Illinois, USA and National Comprehensive Cancer Network (NCCN), USA., Haidinger R; Brustkrebs Deutschland e.V., Munich, Germany., Harbeck N; Breast Centre, University of Munich, Munich and Arbeitsgemeinschaft Gynäkologische Onkologie, Kommission Mamma (AGO Guidelines), Germany., Hu X; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China., Kaur R; Breast Cancer Welfare Association, Petaling Jaya, Malaysia., Kiely B; NHMRC Clinical Trials Centre, Sydney Medical School, Sydney, Australia., Kim SB; Asan Medical Centre, Department of Oncology, Seoul, South Korea., Koppikar S; Lilavati Hospital and Research Centre, Bombay Hospital Institute of Medical Sciences, Asian Cancer Institute, Mumbai, India., Kuper-Hommel MJJ; Te Whatu Ora Waikato, Midland Regional Cancer Centre, NZ ABC Guidelines, Hamilton, New Zealand., Lecouvet FE; Department of Radiology, Institut Roi Albert II and Institut de Recherche Expérimentale et Clinique (IREC), Cliniques Universitaires Saint Luc, Université Catholique de Louvain, Brussels, Belgium., Mason G; Inflammatory Breast Cancer Research Foundation, West Lafayette, USA., Mertz SA; MBC US Alliance and Metastatic Breast Cancer Network US, Inverness, USA., Mueller V; University Medical Center Hamburg-Eppendorf, Hamburg and Arbeitsgemeinschaft Gynäkologische Onkologie, Kommission Mamma (AGO Guidelines), Germany., Myerson C; Breast Cancer Now, London, United Kingdom., Neciosup S; Department of Medical Oncology, National Institute of Neoplastic Diseases, Lima, ABC Latin America Guidelines, Peru., Offersen BV; Department of Oncology, Aarhus University Hospital, Aarhus, European Society for Radiotherapy and Oncology (ESTRO), Denmark., Ohno S; Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan., Pagani O; Hôpital Riviera-Chablais, Vaud-Valais Rennaz, Switzerland., Partridge AH; Dana-Farber Cancer Institute, Department of Medical Oncology and Division of Breast Oncology, Boston, USA and American Society of Clinical Oncology (ASCO), USA., Penault-Llorca F; Centre Jean Perrin, Université Clermont Auvergne, INSERM, U1240 Imagerie Moléculaire et Stratégies Théranostiques, F-63000, Clermont Ferrand, Nice/St Paul Guidelines, France., Prat A; Hospital Clínic of Barcelona, University of Barcelona, Barcelona, Spain., Rugo HS; Breast Oncology and Clinical Trials Education, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA., Senkus E; Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland., Sledge GW; Division of Oncology, Stanford School of Medicine, Stanford, USA., Swain SM; Georgetown University Lombardi Comprehensive Cancer Center and MedStar Health, Washington DC, USA., Thomssen C; Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle (Saale) and Arbeitsgemeinschaft Gynäkologische Onkologie, Kommission Mamma (AGO Guidelines), Germany., Vorobiof DA; Belong.Life, New York, USA., Vuylsteke P; University of Botswana, Gaborone, Botswana and CHU UCL Namur Hospital, UCLouvain, Belgium., Wiseman T; The Royal Marsden NHS Foundation Trust, University of Southampton, United Kingdom and European Oncology Nursing Society (EONS), United Kingdom., Xu B; Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China., Costa A; European School of Oncology, Milan, Italy and Bellinzona, Switzerland., Norton L; Breast Cancer Programs, Memorial Sloan-Kettering Cancer Centre, New York, USA., Winer EP; Yale Cancer Center, Yale University School of Medicine, New Haven, CT, USA.
Publikováno v:
Breast (Edinburgh, Scotland) [Breast] 2024 Aug; Vol. 76, pp. 103756. Date of Electronic Publication: 2024 May 28.
Autor:
Cook S; Tom Baker Cancer Centre, University of Calgary, Calgary, AB T2N 4N2, Canada., Alibhai S; Department of Medicine, University Health Network, University of Toronto, Toronto, ON M5G 2C4, Canada., Mehta R; Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON M4N 3M5, Canada., Savard MF; The Ottawa Hospital Cancer Centre, University of Ottawa, Ottawa, ON K1H 8L6, Canada., Mariano C; BC Cancer Vancouver Centre, University of British Columbia, Vancouver, BC V5Z 4E6, Canada., LeBlanc D; Centre Hospitalier Universitaire de Québec, Université Laval, Québec, QC G1V 0A6, Canada., Desautels D; CancerCare Manitoba, University of Manitoba, Winnipeg, MB R3E 0V9, Canada., Pezo R; Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON M4N 3M5, Canada., Zhu X; Cross Cancer Institute, University of Alberta, Edmonton, AB T6G 1Z2, Canada., Gelmon KA; BC Cancer Vancouver Centre, University of British Columbia, Vancouver, BC V5Z 4E6, Canada., Hsu T; The Ottawa Hospital Cancer Centre, University of Ottawa, Ottawa, ON K1H 8L6, Canada.
Publikováno v:
Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Jun 30; Vol. 31 (7), pp. 3783-3797. Date of Electronic Publication: 2024 Jun 30.
Autor:
Widman AJ; New York Genome Center, New York, NY, USA. widmana@mskcc.org.; Memorial Sloan Kettering Cancer Center, New York, NY, USA. widmana@mskcc.org., Shah M; New York Genome Center, New York, NY, USA., Frydendahl A; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Halmos D; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Khamnei CC; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Øgaard N; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Rajagopalan S; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Arora A; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Deshpande A; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Hooper WF; New York Genome Center, New York, NY, USA., Quentin J; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Bass J; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Zhang M; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Langanay T; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Andersen L; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Steinsnyder Z; New York Genome Center, New York, NY, USA., Liao W; New York Genome Center, New York, NY, USA., Rasmussen MH; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Henriksen TV; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Jensen SØ; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Nors J; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Therkildsen C; Gastro Unit, Copenhagen University Hospital, Amager - Hvidovre Hospital, Hvidovre, Denmark., Sotelo J; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Brand R; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Schiffman JS; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Shah RH; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Cheng AP; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Maher C; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Spain L; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.; Renal and Skin Unit, The Royal Marsden NHS Foundation Trust, London, UK., Krause K; Mass General Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Frederick DT; Mass General Cancer Center, Massachusetts General Hospital, Boston, MA, USA., den Brok W; Department of Medical Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Lohrisch C; Department of Medical Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Shenkier T; Department of Medical Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Simmons C; Department of Medical Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Villa D; Department of Medical Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Mungall AJ; Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada., Moore R; Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada., Zaikova E; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Cerda V; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Kong E; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Lai D; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Malbari MS; Weill Cornell Medicine, New York, NY, USA., Marton M; New York Genome Center, New York, NY, USA., Manaa D; New York Genome Center, New York, NY, USA., Winterkorn L; New York Genome Center, New York, NY, USA., Gelmon K; Department of Medical Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Callahan MK; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Boland G; Mass General Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Potenski C; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Wolchok JD; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Saxena A; Weill Cornell Medicine, New York, NY, USA., Turajlic S; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.; Renal and Skin Unit, The Royal Marsden NHS Foundation Trust, London, UK., Imielinski M; New York Genome Center, New York, NY, USA.; Perlmutter Cancer Center, NYU Grossman School of Medicine, New York, NY, USA., Berger MF; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Aparicio S; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Altorki NK; Weill Cornell Medicine, New York, NY, USA., Postow MA; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Robine N; New York Genome Center, New York, NY, USA., Andersen CL; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Landau DA; New York Genome Center, New York, NY, USA. dlandau@nygenome.org.; Weill Cornell Medicine, New York, NY, USA. dlandau@nygenome.org.
Publikováno v:
Nature medicine [Nat Med] 2024 Jun; Vol. 30 (6), pp. 1655-1666. Date of Electronic Publication: 2024 Jun 14.
Autor:
Fey MF; Former Chairman of the Department of Medical Oncology, Inselspital and University of Bern, Bern, Switzerland., O'Reilly S; Consultant Medical Oncologist, University College Cork, Cork, Ireland., Awada AH; Medical Oncologist, Institut Jules Bordet, Université Libre de Bruxelles, Bruxelles, Belgium., Crowley J; CRAB Cancer Research and Biostatistics, Seattle, Washington, USA., Gelmon KA; University of British Columbia Faculty of Medicine, 2775 Laurel Street, Vancouver, British Columbia, Canada.
Publikováno v:
Current opinion in oncology [Curr Opin Oncol] 2024 Sep 01; Vol. 36 (5), pp. 418-420. Date of Electronic Publication: 2024 Aug 08.
Autor:
Brain E; Department of Medical Oncology, Institut Curie/Saint-Cloud, Paris, France., Chen C; Pfizer Inc., New York, NY, USA., Simon S; Pfizer S.L.U., Madrid, Spain., Pasupuleti V; Oxford PharmaGenesis Inc., Newtown, PA, USA., Pfitzer KV; SHARE Cancer Support, New York, NY, USA., Gelmon KA; Faculty of Medicine, University of British Columbia, and BC Cancer, 600 W 10th Ave, Vancouver, BC, V5Z 1M9, Canada. kgelmon@bccancer.bc.ca.
Publikováno v:
Targeted oncology [Target Oncol] 2024 May; Vol. 19 (3), pp. 303-320. Date of Electronic Publication: 2024 Mar 28.
Autor:
Balmaña J; Medical Oncology Department, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain., Fasching PA; Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Delaloge S; Breast Cancer Unit, Department of Cancer Medicine, Gustave Roussy, Villejuif, France., Labidi-Galy I; Department of Oncology, Geneva University Hospital, Department of Medicine, Division of Oncology, Faculty of Medicine, University of Geneva, Geneva, Switzerland., O'Shaughnessy J; Baylor University Medical Center, Texas Oncology and US Oncology, Dallas, TX, USA., Park YH; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Eisen AF; Division of Medical Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada., You B; Department of Medical Oncology, Hospices Civils of Lyon Cancer Institute, Centre for Therapeutic Investigation in Oncology and Haematology of Lyon, Lyon Sud Hospital Centre, Lyon, France.; Faculty of Medicine of Lyon Sud, Claude Bernard Lyon 1 University, Lyon, France.; GINECO-GINEGEPS, Paris, France., Bourgeois H; Medical Oncology Department, Victor Hugo Clinic-Jean Bernard Center, Le Mans, France., Gonçalves A; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.; Cancer Research Center of Marseille, Aix-Marseille University, French National Centre for Scientific Research, National Institute for Health and Medical Research, Marseille, France., Kemp Z; Breast Cancer Unit, The Royal Marsden NHS Foundation Trust, London, UK., Swampillai A; Department of Clinical Oncology, Guy's and St Thomas' Hospital NHS Foundation Trust, London, UK.; Breast Cancer Now Research Unit, Guy's Hospital, King's College London, London, UK., Jankowski T; Department of Pneumology, Oncology and Allergology, Medical University of Lublin, Lublin, Poland., Sohn JH; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea., Poddubskaya E; Surgical Department N2, Clinical Center VitaMed, Moscow, Russia., Mukhametshina G; Ministry of Health of the Republic of Tatarstan, Kazan, Russia., Aksoy S; Medical Oncology Department, Hacettepe University Cancer Institute, Ankara, Turkey., Timcheva CV; Medical Oncology Department, MHAT Nadezhda, Sofia, Bulgaria., Park-Simon TW; Frauenklinik, Hannover Medical School, Hannover, Germany., Antón-Torres A; Department of Medical Oncology, Miguel Servet University Hospital and Aragon Health Research Institute, Zaragoza, Spain., John E; Statistics, AstraZeneca, Cambridge, UK., Baria K; US Medical Affairs, AstraZeneca, Gaithersburg, MD, USA., Gibson I; Global Medical Affairs, AstraZeneca, Cambridge, UK., Gelmon KA; Department of Medical Oncology, BC Cancer, University of British Columbia, Vancouver, Canada. kgelmon@bccancer.bc.ca.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Apr; Vol. 204 (2), pp. 237-248. Date of Electronic Publication: 2023 Dec 19.
Autor:
Slamon DJ; David Geffen School of Medicine at University of California Los Angeles, Santa Monica, CA., Diéras V; Centre Eugène Marquis, Rennes Cedex, France., Rugo HS; University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA., Harbeck N; Brustzentrum, Frauenklinik and CCC Munich, LMU University Hospital, Munich, Germany., Im SA; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea., Gelmon KA; BC Cancer, Vancouver, BC, Canada., Lipatov ON; SAHI Republican Clinical Oncology Dispensary under the MoH of Russia, Ufa, Russia., Walshe JM; Cancer Trials Ireland, St Vincent's University Hospital, Dublin, Ireland., Martin M; Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, GEICAM, Madrid, Spain., Chavez-MacGregor M; The University of Texas MD Anderson Cancer Center, Houston, TX., Bananis E; Pfizer Inc, New York, NY., Gauthier E; Pfizer Inc, San Francisco, CA., Lu DR; Pfizer Inc, San Diego, CA., Kim S; Pfizer Inc, San Diego, CA., Finn RS; David Geffen School of Medicine at University of California Los Angeles, Santa Monica, CA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Mar 20; Vol. 42 (9), pp. 994-1000. Date of Electronic Publication: 2024 Jan 22.
Autor:
LeVasseur N; Division of Medical Oncology, BC Cancer, Vancouver, BC, Canada.; Department of Medicine, University of British Columbia, Vancouver, BC, Canada., Gelmon KA; Division of Medical Oncology, BC Cancer, Vancouver, BC, Canada.; Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
Publikováno v:
Translational cancer research [Transl Cancer Res] 2024 Jan 31; Vol. 13 (1), pp. 1-5. Date of Electronic Publication: 2024 Jan 29.
Autor:
Zaikova E; Molecular Oncology, BC Cancer, 675 W10th Avenue, Vancouver, Canada., Cheng BYC; Molecular Oncology, BC Cancer, 675 W10th Avenue, Vancouver, Canada., Cerda V; Molecular Oncology, BC Cancer, 675 W10th Avenue, Vancouver, Canada., Kong E; Molecular Oncology, BC Cancer, 675 W10th Avenue, Vancouver, Canada., Lai D; Molecular Oncology, BC Cancer, 675 W10th Avenue, Vancouver, Canada., Lum A; Molecular Oncology, BC Cancer, 675 W10th Avenue, Vancouver, Canada., Bates C; Molecular Oncology, BC Cancer, 675 W10th Avenue, Vancouver, Canada., den Brok W; Medical Oncology, BC Cancer, 600 W10th Avenue, Vancouver, Canada., Kono T; Molecular Oncology, BC Cancer, 675 W10th Avenue, Vancouver, Canada., Bourque S; Medical Oncology, BC Cancer, 13750 96 Ave, Surrey, Canada., Chan A; Medical Oncology, BC Cancer, 13750 96 Ave, Surrey, Canada., Feng X; Medical Oncology, BC Cancer, 2410 Lee Ave, Victoria, Canada., Fenton D; Medical Oncology, BC Cancer, 2410 Lee Ave, Victoria, Canada., Gurjal A; Medical Oncology, BC Cancer, 32900 Marshall Rd, Abbotsford, Canada., Levasseur N; Medical Oncology, BC Cancer, 600 W10th Avenue, Vancouver, Canada., Lohrisch C; Medical Oncology, BC Cancer, 600 W10th Avenue, Vancouver, Canada., Roberts S; Medical Oncology, BC Cancer, 1215 Lethbridge St, Prince George, Canada., Shenkier T; Medical Oncology, BC Cancer, 600 W10th Avenue, Vancouver, Canada., Simmons C; Medical Oncology, BC Cancer, 600 W10th Avenue, Vancouver, Canada., Taylor S; Medical Oncology, BC Cancer, 399 Royal Ave, Kelowna, Canada., Villa D; Medical Oncology, BC Cancer, 600 W10th Avenue, Vancouver, Canada., Miller R; Imagia Canexia Health, 204-2389 Health Sciences Mall, Vancouver, Canada., Aguirre-Hernandez R; Imagia Canexia Health, 204-2389 Health Sciences Mall, Vancouver, Canada., Aparicio S; Molecular Oncology, BC Cancer, 675 W10th Avenue, Vancouver, Canada. saparicio@bccrc.ca., Gelmon K; Medical Oncology, BC Cancer, 600 W10th Avenue, Vancouver, Canada. kgelmon@bccancer.bc.ca.
Publikováno v:
NPJ breast cancer [NPJ Breast Cancer] 2024 Jan 05; Vol. 10 (1), pp. 3. Date of Electronic Publication: 2024 Jan 05.